TABLE 2.
Placebo group | Vitamin D group | |||
---|---|---|---|---|
Composite event count | Number of subjects | Percentage of group | Number of subjects | Percentage of group |
0 | 5 | 11.11 | 12 | 26.07 |
1 | 16 | 35.56 | 13 | 28.26 |
2 | 8 | 17.78 | 4 | 8.70 |
3 | 8 | 17.78 | 7 | 15.22 |
4 | 5 | 11.11 | 5 | 10.87 |
6 | 2 | 4.44 | 4 | 8.70 |
7 | 1 | 2.22 | 1 | 2.17 |
Total | 45 | 100.00 | 46 | 100.00 |
1The number of composite events by total count of events (pulmonary exacerbation of cystic fibrosis) is divided by randomization group: vitamin D or placebo. All of the composite events represented pulmonary exacerbations except for 3 deaths in the vitamin D group.